[{"address1": "10 Earlsfort Terrace", "city": "Dublin", "zip": "D02 T380", "country": "Ireland", "phone": "353 1 901 5201", "website": "https://www.avadel.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland.", "fullTimeEmployees": 188, "companyOfficers": [{"maxAge": 1, "name": "Mr. Gregory J. Divis Jr.", "age": 58, "title": "CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 677400, "exercisedValue": 0, "unexercisedValue": 9165075}, {"maxAge": 1, "name": "Mr. Thomas S. McHugh", "age": 60, "title": "Senior VP, Principal Financial & Accounting Officer and CFO", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 530119, "exercisedValue": 0, "unexercisedValue": 3787375}, {"maxAge": 1, "name": "Mr. Jerad G. Seurer", "age": 51, "title": "General Counsel, Company Secretary & Compliance Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 634700, "exercisedValue": 268784, "unexercisedValue": 1071694}, {"maxAge": 1, "name": "Ms. Susan  Rodriguez", "age": 60, "title": "Chief Operating Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gregory J. Davis", "age": 60, "title": "VP of Corporate and Business Development", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angie  Woods", "title": "Vice President of People & Culture", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jason M. Vaughn Ph.D., R.Ph.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Gudeman PharmD", "title": "Senior Vice President of Medical & Clinical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Polly A. Murphy D.V.M., M.B.A., Ph.D.", "age": 60, "title": "Chief Business Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Marla  Scarola M.S.", "title": "Senior Vice President of Regulatory & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 7, "shareHolderRightsRisk": 3, "overallRisk": 4, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 21.53, "open": 21.53, "dayLow": 21.5, "dayHigh": 21.5456, "regularMarketPreviousClose": 21.53, "regularMarketOpen": 21.53, "regularMarketDayLow": 21.5, "regularMarketDayHigh": 21.5456, "payoutRatio": 0.0, "trailingPE": "Infinity", "forwardPE": 27.45078, "volume": 571197, "regularMarketVolume": 571197, "averageVolume": 2074255, "averageVolume10days": 2164550, "averageDailyVolume10Day": 2164550, "bid": 15.48, "ask": 27.6, "bidSize": 2, "askSize": 2, "marketCap": 2110256640, "fiftyTwoWeekLow": 6.38, "fiftyTwoWeekHigh": 23.57, "allTimeHigh": 43.6, "allTimeLow": 0.71, "priceToSalesTrailing12Months": 8.491398, "fiftyDayAverage": 21.5186, "twoHundredDayAverage": 14.46005, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2045419264, "profitMargins": -0.00112, "floatShares": 80999367, "sharesOutstanding": 98151471, "sharesShort": 2730297, "sharesShortPriorMonth": 3906360, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0278, "heldPercentInsiders": 0.01056, "heldPercentInstitutions": 0.95988, "shortRatio": 1.78, "shortPercentOfFloat": 0.028099999, "impliedSharesOutstanding": 98151471, "bookValue": 1.01, "priceToBook": 21.287128, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -278000, "trailingEps": 0.0, "forwardEps": 0.78322, "enterpriseToRevenue": 8.231, "enterpriseToEbitda": 757.843, "52WeekChange": 1.8744993, "SandP52WeekChange": 0.14987159, "quoteType": "EQUITY", "currentPrice": 21.5, "targetHighPrice": 23.0, "targetLowPrice": 18.5, "targetMeanPrice": 20.9375, "targetMedianPrice": 21.25, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 8, "totalCash": 91577000, "totalCashPerShare": 0.938, "ebitda": 2699000, "totalDebt": 37378000, "quickRatio": 2.145, "currentRatio": 2.756, "totalRevenue": 248516992, "debtToEquity": 38.053, "revenuePerShare": 2.57, "returnOnAssets": -0.00341, "returnOnEquity": -0.00322, "grossProfits": 235878000, "freeCashflow": 2729625, "operatingCashflow": 34543000, "revenueGrowth": 0.549, "grossMargins": 0.94914, "ebitdaMargins": 0.01086, "operatingMargins": 0.025, "financialCurrency": "USD", "symbol": "AVDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -0.139344, "regularMarketPrice": 21.5, "shortName": "Avadel Pharmaceuticals plc", "longName": "Avadel Pharmaceuticals plc", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1769206481, "regularMarketTime": 1769202002, "exchange": "NGM", "messageBoardId": "finmb_28567", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyTwoWeekLowChange": 15.12, "fiftyTwoWeekLowChangePercent": 2.369906, "fiftyTwoWeekRange": "6.38 - 23.57", "fiftyTwoWeekHighChange": -2.0699997, "fiftyTwoWeekHighChangePercent": -0.087823495, "fiftyTwoWeekChangePercent": 187.44994, "earningsTimestamp": 1762290000, "earningsTimestampStart": 1762290000, "earningsTimestampEnd": 1762290000, "earningsCallTimestampStart": 1754569800, "earningsCallTimestampEnd": 1754569800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.0, "epsForward": 0.78322, "epsCurrentYear": 0.27719, "priceEpsCurrentYear": 77.564125, "fiftyDayAverageChange": -0.018600464, "fiftyDayAverageChangePercent": -0.00086439005, "twoHundredDayAverageChange": 7.0399504, "twoHundredDayAverageChangePercent": 0.4868552, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "3.0 - Hold", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 834154200000, "postMarketChangePercent": 0.0, "postMarketPrice": 21.5, "postMarketChange": 0.0, "regularMarketChange": -0.0300007, "regularMarketDayRange": "21.5 - 21.5456", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2074255, "displayName": "Avadel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]